| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Ratings for Universal Health Services (NYSE:UHS) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 4 | 5 | 1 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 3 | 0 | 0 |
| 3M Ago | 0 | 1 | 1 | 1 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $221.1, with a high estimate of $259.00 and a low estimate of $185.00. This current average has decreased by 2.98% from the previous average price target of $227.90.
The standing of Universal Health Services among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Stephen Baxter | Wells Fargo | Raises | Overweight | $249.00 | $210.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Neutral | $227.00 | $227.00 |
| Andrew Mok | Barclays | Lowers | Overweight | $250.00 | $259.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Neutral | $227.00 | $227.00 |
| Ben Hendrix | RBC Capital | Raises | Sector Perform | $206.00 | $201.00 |
| Michael Ha | Baird | Lowers | Neutral | $203.00 | $243.00 |
| Stephen Baxter | Wells Fargo | Lowers | Overweight | $210.00 | $225.00 |
| Benjamin Rossi | JP Morgan | Lowers | Neutral | $195.00 | $215.00 |
| Andrew Mok | Barclays | Raises | Overweight | $259.00 | $257.00 |
| Kevin Fischbeck | B of A Securities | Lowers | Underperform | $185.00 | $215.00 |
For valuable insights into Universal Health Services's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Universal Health Services analyst ratings.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Universal Health Services's remarkable performance in 3M is evident. As of 30 June, 2025, the company achieved an impressive revenue growth rate of 9.63%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 8.25%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Universal Health Services's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.11% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Universal Health Services's ROA excels beyond industry benchmarks, reaching 2.37%. This signifies efficient management of assets and strong financial health.
Debt Management: Universal Health Services's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.71.
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: UHS
